Bluedrop Medical key facts
as of Oct 2026- Developer of a diabetic foot monitoring device designed to enable early detection of foot ulcers.
- Bluedrop Medical is valued at approximately $127.9M as of Oct 2026 (last reported valuation).
- It has raised $30.3M; the latest was Later Stage VC ($11.7M) in Dec 2025.
- Notable investors include Enterprise Ireland, European Innovation Council, Elkstone, Atlantic Bridge Capital, Western Development Commission — 18 tracked in total.
- Status: Privately Held (backing).
Bluedrop Medical's last reported valuation, Dec 2025. Nothing priced has surfaced since.
- ·The complete investor list: 18 names
- ·Watch Bluedrop Medical: the Monday email on marks, rounds and moves
Bluedrop Medical funding rounds
No funding rounds for Bluedrop Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Bluedrop Medical
18+Bluedrop Medical valuation
Bluedrop Medical's last reported valuation was $128 million in Dec 2025. No priced round, secondary trade or fund mark has surfaced since.
Bluedrop Medical investors
18 investors are on record for Bluedrop Medical, including Enterprise Ireland, European Innovation Council, Elkstone and Atlantic Bridge Capital.
About Bluedrop Medical
Developer of a diabetic foot monitoring device designed to enable early detection of foot ulcers. The company's device conducts daily foot scans and transmits data to the cloud for algorithmic analysis, enabling healthcare providers to identify complications sooner, prevent amputations, and improve patient outcomes while reducing treatment costs.
- Sector
- Healthcare
- HQ
- Galway, Ireland
- Founded
- 2014
- Employees
- 23
- Website
- bluedropmedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.